Cargando…
Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123
Current therapies for acute myeloid leukemia (AML), are associated with high relapse rates. Hence, development of new therapeutic strategies is crucial to circumvent this problem. Bivalent antibody technology has been used to engineer novel antibody fragments with increased avidity, by assembling tw...
Autores principales: | Moradi-Kalbolandi, Shima, Habibi-Anbouhi, Mahdi, Golkar, Majid, Behdani, Mahdi, Rezaei, Gashin, Ghazizadeh, Leila, Abolhassani, Mohsen, Shokrgozar, Mohammad Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976644/ https://www.ncbi.nlm.nih.gov/pubmed/27536714 http://dx.doi.org/10.1016/j.dib.2016.07.014 |
Ejemplares similares
-
Enhancement of keratinocyte growth factor potential in inducing adipose‐derived stem cells differentiation into keratinocytes by collagen‐targeting
por: Amidzadeh, Zahra, et al.
Publicado: (2022) -
Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2018) -
Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021) -
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021) -
Expressing of Recombinant VEGFR2-specific Nanobody in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2021)